Single-cell analysis reveals the intra-tumor heterogeneity and identifies MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma | Cell Death Discovery
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
EGFR activation limits the response of liver cancer to lenvatinib | Nature
Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma - ScienceDirect
Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma | Cell Death & Disease
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma | Nature Communications
EGFR activation limits the response of liver cancer to lenvatinib | Nature
miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma
Liver Cancer Tumor Markers | GeneTex
Sensitivity of markers used to prove hepatocellular carcinoma (HCC)... | Download Scientific Diagram
epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC) | medRxiv
Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation - ScienceDirect
Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance | Cell Death Discovery
The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma
Gal-1 is a CAF marker and is correlated with the poor prognosis of... | Download Scientific Diagram
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Oncogene
Tumor markers for hepatocellular carcinoma (Review)
CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma
obbvie
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis | SpringerLink
Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers | Scientific Reports
Frontiers | Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma | Cancer Cell International | Full Text
Advances in immunotherapy for hepatocellular carcinoma | Nature Reviews Gastroenterology & Hepatology
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma | Nature Communications
